J Low Genit Tract Dis
Cervix UteriEarly Detection of CancerMass Screening
Dr. Scott E. Lentz, MD
NPI1477620490PAC ID6103863766
- Part D claims, 2024
- 77
- Publications
- 9
- Clinical trials
- 17
- Hospital affiliations
- 1
- Industry payments
- $375
- Practice address
- 6041 Cadillac Ave, Los Angeles, CA 90034
- Practice phone
- Call (213) 857-2201
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Lentz's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Scott E. Lentz is a gynecologic oncologist in Los Angeles, California
Dr. Lentz practices at West Los Angeles Medical Center in Los Angeles, California, part of Kaiser Permanente.
Dr. Lentz's NPI, 1477620490, was assigned on November 29, 2006. Dr. Lentz graduated from Penn State College of Medicine in 1994. Dr. Lentz holds California license A65034.
NPI and contact details
- NPI
- 1477620490NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6103863766
- NPI enumeration date
- November 29, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (213) 857-2201
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 58
- Medical school graduation
- 1994
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Scott E. Lentz practices at West Los Angeles Medical Center in Los Angeles, California
Dr. Lentz's primary practice is West Los Angeles Medical Center, at 6041 Cadillac Ave, Los Angeles, CA 90034 in Los Angeles County. The practice phone is (213) 857-2201.
- West Los Angeles Medical Center6041 Cadillac Ave, Los Angeles, CA 90034 · Los Angeles CountyPhone(213) 857-2201
Source: Dmand AI Affiliation Data
Dr. Scott E. Lentz is affiliated with 3 sites of care and 1 medical group
Dr. Lentz's primary practice is West Los Angeles Medical Center in Los Angeles, California, part of Kaiser Permanente. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Lentz to 1 more dialysis center and 1 group practice or clinic, each named with a free account.
Southern California Permanente Medical Group1 dialysis centerName with a free account1 group practice or clinicName with a free account
See all 4 affiliations for Dr. LentzSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Scott E. Lentz's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lentz practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| West Los Angeles Medical Center | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Lentz practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Kaiser Permanente and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Scott E. Lentz is one of 178 gynecologic oncologists in California
Gynecologic oncology is Dr. Lentz's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Lentz is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Lentz's licenses on file in 3 states: California, Hawaii and Pennsylvania.
Specialties and state licenses
- Gynecologic oncology, CaliforniaPrimary
- Hawaii license
- Pennsylvania license
Gynecologic oncologists near Dr. Lentz
Counts of gynecologic oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Scott E. Lentz's patients have a median age of 66
Across all payers, Dmand AI patient panel data puts Dr. Lentz's median patient age at 66, with 94% women.
Dr. Lentz's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 66
Patient panel by sex, all payers
- Women94%
- Men6%
Source: Dmand AI Patient Panel Data
Dr. Scott E. Lentz wrote 77 Medicare Part D claims in 2024
In 2024, Dr. Lentz wrote 77 Medicare Part D claims for 35 patients. 84% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $159 in total drug cost. In 2023, CMS named 40 claims across 3 drugs.
Part D claims, 202477
Drugs named by CMS1
Total drug cost$159
Part D patients35
Dr. Lentz's Part D claims by kind of drug, 2024
- Generic65 claims84%
- Brand-name12 claims16%
Dr. Lentz's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 402024: 1563%
Drugs named by CMS: 1 in 2024, 3 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Scott E. Lentz takes part in Medicare
Dr. Lentz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)
Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Find gynecologic oncologists like Dr. Lentz by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Scott E. Lentz has 9 publications on record
Dmand AI links 9 papers to Dr. Lentz, published from 2011 to 2023. 2020 was the busiest year, with 2. Dr. Lentz's most frequent co-authors are Allison E. Axtell, MD, Monica Avila, MD and Robert E. Bristow, MD.
Papers9
Years published2011 to 2023
Dr. Lentz's papers by year, 2011 to 2023
Dr. Lentz's most frequent co-authors
- Allison E. Axtell, MD2 shared papers
- Monica Avila, MD1 shared paper
- Robert E. Bristow, MD1 shared paper
Recent publications by Dr. Lentz
See who Dr. Lentz researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lentz works with, so you can find a warm path to the right gynecologic oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Scott E. Lentz has worked on 17 clinical trials
Dmand AI links Dr. Lentz to 17 clinical trials, 11 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Brenner Tumor, Carcinosarcoma and Lymphedema. GOG Foundation sponsors the most, 6.
Clinical trials with Dr. Lentz by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 2Phase 2/3: 2 trials
- 11Phase 3: 11 trials
- NonePhase 4: no trials
Conditions in Dr. Lentz's trials
- Brenner Tumor
- Carcinosarcoma
- Lymphedema
- Ovarian Neoplasms
- Neoplasms, Complex and Mixed
Investigators on the most trials with Dr. Lentz
- Steven E. Waggoner, MD9 shared trials
- Peter C. Lim, MD8 shared trials
- Andrew Emmons Green, MD7 shared trials
Recent clinical trials with Dr. Lentz
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer (opens in a new tab)
Active, not recruitingPhase 3
CarcinosarcomaNeoplasms, Complex and MixedCarboplatinPaclitaxelPembrolizumab
Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer (opens in a new tab)
Active, not recruitingPhase 3
Ovarian NeoplasmsOvarian DiseasesStandard Chemotherapy
A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer (opens in a new tab)
Active, not recruitingPhase 3
Ovarian NeoplasmsOvarian DiseasesNiraparibStandard of careDostarlimab (TSR-042)
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (opens in a new tab)
Active, not recruitingPhase 2/3
Fallopian Tube DiseasesFallopian Tube NeoplasmsAtezolizumabBevacizumabPegylated Liposomal Doxorubicin Hydrochloride
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer (opens in a new tab)
Status unknownPhase 2/3
CarboplatinMetformin HydrochloridePaclitaxel
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Scott E. Lentz received $375 in industry payments from 2020 to 2023
CMS Open Payments shows 5 general payments to Dr. Lentz from 5 drug and device companies from 2020 to 2023. Food and beverage make up the largest share, 100% of the total. DySIS Medical, Inc. paid the most, $124.
General payments to Dr. Lentz by program year, 2020 to 2023
Companies that paid Dr. Lentz the most, 2020 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Scott E. Lentz has 6 awards and honors on record
Dmand AI lists 6 awards for Dr. Lentz, most recently Top Doctors in 2012.
Awards and honors for Dr. Lentz
- 2012
- Top Doctors
- 2011
- CMS Stage 1 2012
- CREOG Faculty Award for Excellence in Resident Education
- 2003
- Earl Henriksen Award, Outstanding Attending Physician
- Outstanding Teaching Award
- 2001
- Outstanding Fellow
Source: Dmand AI Professional Profile Data
Dr. Scott E. Lentz graduated from Penn State College of Medicine
Dr. Lentz graduated from Penn State College of Medicine in 1994.
- Medical school
- Board certified in gynecologic oncology
- Board certified in obstetrics & gynecology
Source: Dmand AI Professional Profile Data
Dr. Scott E. Lentz accepts plans from 2 insurance carriers
Dr. Lentz is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
- Kaiser Permanente
- CMS Medicare
Plan types Dr. Lentz accepts, by number of carriers
- EPO1
- HMO1
- Medicare1
- POS1
Source: Dmand AI Insurance Network Data
Sources for Dr. Scott E. Lentz's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Scott E. Lentz
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Scott E. Lentz's NPI number?
Dr. Scott E. Lentz's NPI number is 1477620490. It was assigned on November 29, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Scott E. Lentz?
Dr. Scott E. Lentz is a gynecologic oncologist in Los Angeles, California. The primary specialty in the NPI Registry is Gynecologic Oncology Physician (taxonomy code 207VX0201X).
Where does Dr. Scott E. Lentz practice?
Dr. Lentz practices at 6041 Cadillac Ave, Los Angeles, CA 90034. Dr. Lentz's primary practice is West Los Angeles Medical Center in Los Angeles, California, part of Kaiser Permanente. Dmand AI also links Dr. Lentz to 1 dialysis center and 1 group practice or clinic.
What is Dr. Scott E. Lentz's office phone number?
The practice phone on file for Dr. Lentz is (213) 857-2201.
What is Dr. Scott E. Lentz's medical license number?
Dr. Lentz holds California license A65034, one of the licenses on file in 3 states.
Which states has Dr. Scott E. Lentz been licensed in?
Dmand AI has state licenses on file for Dr. Lentz in California (1998 to 2026), Hawaii (2012 to 2018) and Pennsylvania (1995 to 1998).
Which hospitals is Dr. Scott E. Lentz affiliated with?
Dr. Lentz practices at West Los Angeles Medical Center in Los Angeles, California.
What medical group is Dr. Scott E. Lentz part of?
Dr. Lentz is linked to Southern California Permanente Medical Group.
Does Dr. Scott E. Lentz accept Medicare?
Yes. CMS lists Dr. Lentz as accepting Medicare assignment.
Is Dr. Scott E. Lentz board certified?
Yes. Dr. Lentz is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology.
Show 7 more questionsShow fewer questions
Where did Dr. Scott E. Lentz go to medical school?
Dr. Lentz graduated from Penn State College of Medicine in 1994.
What drugs does Dr. Scott E. Lentz prescribe most?
In 2024 Medicare Part D data, Dr. Lentz's most prescribed drugs by claims were Ondansetron HCl.
Has Dr. Scott E. Lentz received payments from drug or device companies?
CMS Open Payments shows $375 in general payments to Dr. Lentz from 5 companies from 2020 to 2023. The largest total came from DySIS Medical, Inc.
How long has Dr. Scott E. Lentz been practicing?
Dr. Lentz graduated from medical school in 1994, 32 years ago.
Does Dr. Scott E. Lentz do research?
Dmand AI links 9 publications to Dr. Lentz, published from 2011 to 2023. Dr. Lentz has worked on 17 clinical trials.
Who does Dr. Scott E. Lentz publish with?
Dr. Lentz's most frequent co-authors are Allison E. Axtell, MD (2 shared papers), Monica Avila, MD (1 shared paper) and Robert E. Bristow, MD (1 shared paper).
What insurance does Dr. Scott E. Lentz accept?
Dr. Lentz is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
Selling to gynecologic oncology practices?
See gynecologic oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card